TrialClinical cancer research : an official journal of the American Association for Cancer Research2015

A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer.

Neeta Pandit-Taskar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.